Your browser doesn't support javascript.
loading
Origins of leukaemia in children with Down syndrome.
Hitzler, Johann K; Zipursky, Alvin.
Afiliação
  • Hitzler JK; Department of Pediatrics, Division of Hematology/Oncology, The Hospital for Sick Children, University of Toronto, Ontario, Canada. johann.hitzler@sickkids.ca
Nat Rev Cancer ; 5(1): 11-20, 2005 Jan.
Article em En | MEDLINE | ID: mdl-15630411
ABSTRACT
Transient megakaryoblastic leukaemia is found in 10% of newborns with Down syndrome, characterized by constitutional trisomy 21. Although in most cases the leukaemic cells disappear spontaneously after the first months of life, irreversible acute megakaryoblastic leukaemia develops in 20% of these individuals within 4 years. The leukaemic cells typically harbour somatic mutations of the gene encoding GATA1, an essential transcriptional regulator of normal megakaryocytic differentiation. Leukaemia that specifically arises in the context of constitutional trisomy 21 and somatic GATA1 mutations is a unique biological model of the incremental process of leukaemic transformation.
Assuntos
Buscar no Google
Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Leucemia Megacarioblástica Aguda / Síndrome de Down Tipo de estudo: Prognostic_studies Limite: Child / Child, preschool / Humans / Infant / Newborn Idioma: En Revista: Nat Rev Cancer Ano de publicação: 2005 Tipo de documento: Article
Buscar no Google
Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Leucemia Megacarioblástica Aguda / Síndrome de Down Tipo de estudo: Prognostic_studies Limite: Child / Child, preschool / Humans / Infant / Newborn Idioma: En Revista: Nat Rev Cancer Ano de publicação: 2005 Tipo de documento: Article